(Q36590690)

15 August 2017

Association between anti-TNF-α therapy and all-cause mortality (English)

1 reference

15 August 2017

0 references

6

Jeffrey R Curtis

1 reference

15 August 2017

5

Marsha A Raebel

1 reference

15 August 2017

8

Daniel H Solomon

1 reference

15 August 2017

10

James D Lewis

1 reference

15 August 2017

4

Leslie R Harrold

1 reference

15 August 2017

1

Lisa J Herrinton

1 reference

15 August 2017

7

Marie R Griffin

1 reference

15 August 2017

Liyan Liu

2

1 reference

15 August 2017

Lang Chen

series ordinal

3

1 reference

15 August 2017

Kenneth G Saag

series ordinal

9

1 reference

15 August 2017

15 October 2012

1 reference

Pharmacoepidemiology and Drug Safety

15 August 2017

1 reference

15 August 2017

21

1 reference

15 August 2017

12

1 reference

15 August 2017

1311-1320

1 reference

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

The effect of insurance status on mortality and procedural use in critically ill patients.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

The widening mortality gap between rheumatoid arthritis patients and the general population

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3565563

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

9 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPDS.3354

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPDS.3354

Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPDS.3354

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23065964

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/PDS.3354

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23065964

1 reference